Assessment of the Effects of Antiretroviral Medications on Kidney Status in Rwanda

Christian Mugabo
{"title":"Assessment of the Effects of Antiretroviral Medications on Kidney Status in Rwanda","authors":"Christian Mugabo","doi":"10.23880/act-16000257","DOIUrl":null,"url":null,"abstract":"According to the previous research, ART over different durations of time has an effect on the nephron as well as on liver hepatoxicity by inducing toxicity. Renal dysfunction by ART has been associated primarily with tenofovir disoproxil, which is actively accumulated in the proximal renal tubule. CKD is the major problem in ART patients and can lead to loss of kidney function, leading to complications and kidney failure, and development of cardiovascular disease. The main objectives of this study was to assess the effect of antiretroviral drugs on kidney function among the patients attended Nyanza DH during the period of two years. The research is retrospective study done to identify the effect of antiretroviral drugs on kidney Status in Nyanza DH. In total, 755 patients received the antiretroviral medications in Nyanza DH during a period of two years from the 1st of January 2015 to the 31st of December 2017. However 98 patients had data complying with the objective of this study. Those patients with kidney tests conducted every 6months, with elevated CD4 count, and eliminated viral charge. Furthermore nephrotoxicity incidence was considered for both higher concentration of Serum creatinine and lower creatinine Clearance. The results showed that among 98 patients, 24.4% had kidney dysfunction characterized by elevated serum creatinine level at the beginning of treatment. After 6, 12 and 18 months of treatment the percentages of patients with elevated serum creatinine increased to 41.8%, 48.9 % and 50% respectively. It was found that the severity of the problem depends on: combinations the patient is taking, duration of exposure, and other medications the patient is using in combination. In this context it was found that 96.7% of patients that developed nephrotoxicity after 18months were using TDF .The results showed a higher frequency of nephrotoxicity in the population of the study. Therefore, a systematic kidney function monitoring from the beginning of the treatment should be of a great importance, those test could help to take appropriate measures.","PeriodicalId":134434,"journal":{"name":"Advances in Clinical Toxicology","volume":"5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Clinical Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23880/act-16000257","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

According to the previous research, ART over different durations of time has an effect on the nephron as well as on liver hepatoxicity by inducing toxicity. Renal dysfunction by ART has been associated primarily with tenofovir disoproxil, which is actively accumulated in the proximal renal tubule. CKD is the major problem in ART patients and can lead to loss of kidney function, leading to complications and kidney failure, and development of cardiovascular disease. The main objectives of this study was to assess the effect of antiretroviral drugs on kidney function among the patients attended Nyanza DH during the period of two years. The research is retrospective study done to identify the effect of antiretroviral drugs on kidney Status in Nyanza DH. In total, 755 patients received the antiretroviral medications in Nyanza DH during a period of two years from the 1st of January 2015 to the 31st of December 2017. However 98 patients had data complying with the objective of this study. Those patients with kidney tests conducted every 6months, with elevated CD4 count, and eliminated viral charge. Furthermore nephrotoxicity incidence was considered for both higher concentration of Serum creatinine and lower creatinine Clearance. The results showed that among 98 patients, 24.4% had kidney dysfunction characterized by elevated serum creatinine level at the beginning of treatment. After 6, 12 and 18 months of treatment the percentages of patients with elevated serum creatinine increased to 41.8%, 48.9 % and 50% respectively. It was found that the severity of the problem depends on: combinations the patient is taking, duration of exposure, and other medications the patient is using in combination. In this context it was found that 96.7% of patients that developed nephrotoxicity after 18months were using TDF .The results showed a higher frequency of nephrotoxicity in the population of the study. Therefore, a systematic kidney function monitoring from the beginning of the treatment should be of a great importance, those test could help to take appropriate measures.
评估卢旺达抗逆转录病毒药物对肾脏状况的影响
根据以往的研究,不同时间的抗逆转录病毒治疗通过诱导毒性对肾细胞和肝脏的肝毒性产生影响。抗逆转录病毒治疗引起的肾功能障碍主要与替诺福韦二氧吡酯有关,后者在近端肾小管中主动积累。慢性肾病是抗逆转录病毒治疗患者的主要问题,可导致肾功能丧失,导致并发症和肾衰竭,并发展为心血管疾病。本研究的主要目的是评估抗逆转录病毒药物对Nyanza DH患者两年期间肾功能的影响。该研究是一项回顾性研究,旨在确定抗逆转录病毒药物对Nyanza DH肾脏状况的影响。在2015年1月1日至2017年12月31日的两年间,共有755名患者在Nyanza DH接受了抗逆转录病毒药物治疗。然而,有98例患者的数据符合本研究的目的。这些患者每6个月进行一次肾脏检查,CD4计数升高,病毒电荷消除。此外,肾毒性的发生率被认为是血清肌酐浓度较高和肌酐清除率较低。结果显示,98例患者中,24.4%的患者在治疗初期出现以血清肌酐水平升高为特征的肾功能不全。治疗6个月、12个月和18个月后,血清肌酐升高的患者比例分别增加到41.8%、48.9%和50%。研究发现,问题的严重程度取决于:患者正在服用的药物组合,暴露的持续时间,以及患者正在联合使用的其他药物。在这种情况下,发现96.7%的患者在使用TDF 18个月后发生肾毒性,结果显示在研究人群中肾毒性的频率更高。因此,从治疗之初就进行系统的肾功能监测是非常重要的,这些检测有助于采取相应的措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信